Bishop, Kate
McMorrow, Meredith
Meiring, Susan
Walaza, Sibongile
Rossi, Liza
Mhlanga, Sarona
Tempia, Stefano
Mathunjwa, Azwifarwi
Kleynhans, Jackie
Appiah, Grace D.
McAnerney, Johanna M.
Zar, Heather J.
Cohen, Cheryl
Article History
Received: 18 May 2021
Accepted: 31 August 2021
First Online: 9 September 2021
Declarations
:
: The augmented influenza vaccination campaign among pregnant women was part of the study of antenatal influenza vaccine effectiveness approved by the University of Witwatersrand Human Research Ethics Committee (certificate M140826) and the Faculty of Health Sciences, University of Cape Town Human Research Ethics Committee (reference 835/ 2014), and all methods were performed in accordance with the relevant guidelines and regulations. The National Health Research Committee and the WC Provincial Health Research Committee also approved the protocol. Informed consent was not required to utilise data from vaccine registers, as these were collected as part of routine healthcare practice in collaboration with the DoH. Verbal informed consent was obtained from staff participating in the IPIE campaign evaluation.
: Not applicable.
: Cheryl Cohen has received grant support from Sanofi Pasteur, Advanced Vaccine Initiative, U.S. Centers for Disease Control and Prevention, and payment of travel costs from Parexel. The rest of the authors have no competing interests to declare.